Amount Raised
$82 Million
Round Type
Funding Round
South San FranciscoManufacturingBiotechnologyDescription
Cellares Corporation, a life sciences technology company that automates cell therapy manufacturing, today announced it has secured $82 million in a Series B round, bringing total funding to date to $100 million. The round was led by new investor Decheng Capital and co-led by existing investor Eclipse Ventures. Skyviews Life Science joined as a new investor, with previous investor 8VC also participating.
Quick answer
Cellares raised $82 Million in a Funding Round round, dated May 5, 2021. Cellares is based in South San Francisco, California, United States.
- How much did Cellares raise?
- Cellares raised $82 Million in a Funding Round round on May 5, 2021.
- What does Cellares do?
- Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century.
- Where is Cellares based and how big is it?
- Cellares is based in South San Francisco, California, United States. Fundz records about 300 employees.
- Who are the decision-makers at Cellares?
- Fundz holds 1 contact at Cellares, including the Co-Founder & CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Cellares, and when
A new round usually means Cellares is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cellares raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cellares, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cellares. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cellares raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cellares raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.